Clinical studies have shown that azithromycin crosses the placenta without signs of harm to the fetus, and there is no information on the secretion of this product in breast milk. The safety of use during breastfeeding has not been confirmed, so azithromycin dispersible tablets may be taken by breastfeeding women when there is no appropriate alternative, but it should be used under the supervision of a doctor and in accordance with the doctor’s instructions. Azithromycin Dispersible Tablets can treat infections caused by sensitive bacteria, such as otitis media, sinusitis, pharyngitis, tonsillitis and other upper respiratory tract infections; bronchitis, pneumonia and other lower respiratory tract infections; skin and soft tissue infections; Chlamydia trachomatis or non-multi-resistant gonococcus caused by simple genital infections. A variety of adverse reactions such as arthralgia, edema, urticaria, tachycardia, constipation, anorexia, dyspepsia, diarrhea and vomiting, fatigue, sensory abnormalities, vaginitis, thrombocytopenia, dizziness, somnolence, tinnitus, and other adverse reactions may occur with the administration of Azithromycin Dispersible Tablets. It is contraindicated in patients who are allergic to azithromycin, erythromycin, other macrolides or ketolactones, and in patients who have a history of cholestatic jaundice or hepatic insufficiency after previous use of azithromycin. If you need to use Azithromycin Dispersible Tablets, please consult a professional doctor, follow the doctor’s instructions, and use medication reasonably.